anmelden
FTSE All-Share
5.835,30
PKT
+40,80
PKT
+0,70
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 12.02.15 | Glencore kaufen | Independent Research GmbH | |
| 12.02.15 | Glencore Underweight | JP Morgan Chase & Co. | |
| 12.02.15 | Sky Neutral | Goldman Sachs Group Inc. | |
| 12.02.15 | Glencore Neutral | UBS AG | |
| 12.02.15 | Shell (ex Royal Dutch Shell) buy | Société Générale Group S.A. (SG) | |
| 12.02.15 | BP Hold | Société Générale Group S.A. (SG) | |
| 12.02.15 | Unilever Neutral | Goldman Sachs Group Inc. | |
| 12.02.15 | Unilever Neutral | Goldman Sachs Group Inc. | |
| 12.02.15 | Diageo Sell | Goldman Sachs Group Inc. | |
| 11.02.15 | Glencore Neutral | Goldman Sachs Group Inc. | |
| 11.02.15 | Rio Tinto Sell | Goldman Sachs Group Inc. | |
| 11.02.15 | Glencore Reduce | Nomura | |
| 11.02.15 | BP Neutral | UBS AG | |
| 10.02.15 | BT Group buy | Nomura | |
| 10.02.15 | Barclays overweight | Morgan Stanley | |
| 10.02.15 | AstraZeneca verkaufen | Barclays Capital | |
| 10.02.15 | Rio Tinto buy | UBS AG | |
| 10.02.15 | GSK verkaufen | JP Morgan Chase & Co. | |
| 09.02.15 | GSK Halten | Independent Research GmbH | |
| 09.02.15 | BT Group buy | Jefferies & Company Inc. | |
| 09.02.15 | Vodafone Group Halten | Independent Research GmbH | |
| 09.02.15 | AstraZeneca buy | UBS AG | |
| 09.02.15 | Rio Tinto overweight | JP Morgan Chase & Co. | |
| 09.02.15 | Unilever Outperform | Bernstein Research | |
| 09.02.15 | Unilever Outperform | Bernstein Research | |
| 06.02.15 | Vodafone Group overweight | JP Morgan Chase & Co. | |
| 06.02.15 | Vodafone Group buy | Citigroup Corp. | |
| 06.02.15 | Vodafone Group overweight | Morgan Stanley | |
| 06.02.15 | Prudential Neutral | JP Morgan Chase & Co. | |
| 06.02.15 | AstraZeneca Neutral | Goldman Sachs Group Inc. | |
| 06.02.15 | Vodafone Group buy | Goldman Sachs Group Inc. | |
| 06.02.15 | BP Neutral | UBS AG | |
| 05.02.15 | GSK Underweight | JP Morgan Chase & Co. | |
| 05.02.15 | AstraZeneca Hold | S&P Capital IQ | |
| 05.02.15 | Rio Tinto buy | Deutsche Bank AG | |
| 05.02.15 | GSK Hold | Deutsche Bank AG | |
| 05.02.15 | BP buy | Deutsche Bank AG | |
| 05.02.15 | Vodafone Group buy | S&P Capital IQ | |
| 05.02.15 | BP Underperform | Credit Suisse Group | |
| 05.02.15 | GSK Sell | UBS AG |
